BPOM hoping for late 2021 start to indigenous vaccine production 13th April 2021
BPOM head Penny Kusumastuti Lukito. Jakarta (ANTARA) - The Food and Drug Supervisory Agency (BPOM) has expressed the hope that mass production of Indonesia s indigenous Red and White vaccine would start in late 2021. Our hope is that by the end of 2021, our nation could produce the Red and White vaccine, said BPOM head Penny Kusumastuti Lukito during a workshop on the Red and White Vaccine here on Tuesday.
Of the six institutions developing the Red and White vaccine, two institutions have made the fastest progress Airlangga University and the Eijkman Institute for Molecular Biology, she disclosed.
Govt focusing on building herd immunity quickly to contain pandemic antaranews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from antaranews.com Daily Mail and Mail on Sunday newspapers.
Bio Farma to receive Eijkman s vaccine seed stock at March-end 15th March 2021
(ANTARA FOTO/M RISYAL HIDAYAT)
he first batch of vaccine seeds will be handed out at the end of March 2021 Jakarta (ANTARA) - The Eijkman Institute for Molecular Biology in Jakarta has planned to hand out its Merah Putih vaccine seeds to state-owned pharmaceutical company Bio Farma at the end of March. The first batch of vaccine seeds will be handed out at the end of March 2021, Head of the Eijkman Institute for Molecular Biology, Amin Soebandrio, told ANTARA here on Monday.
PT Bio Farma is partnering with Eijkman to hold trials and produce the Merah Putih COVID-19 vaccine, developed with a recombinant protein subunit platform.
The number of Indonesians receiving their first dose of the COVID-19 vaccine rose by 216,422 to reach 3,985,596 as of Saturday afternoon, the Health Ministry .
Search Health Ministry s Covid-19 Vaccination spokeswoman Siti Nadia Tarmizi. (Photo Courtesy of the Covid-19 Handling and Economic Recovery Committee) Enhanced 3Ts Helps Indonesia Detect New Covid-19 Variant MARCH 08, 2021
Jakarta. Indonesia announced last week that it had identified two new cases of the B.1.1.7 coronavirus variant, which was first detected in the UK late last year.
According to Health Ministry’s vaccination spokeswoman Siti Nadia Tarmizi, enhanced Covid testing, tracing, and treatment (3Ts) enabled the government to detect the new variant. In this regard, she specifically referred to the government’s efforts in improving the whole genome sequencing (WGS) of positive specimens as well as the lab’s capacity to detect new virus variants across the archipelago. “The finding [of the new virus variant] illustrates the ability and capacity of the Health Ministry’s Research and Development Agency in performing WGS,” Nadi